ENThere is no single answer to which is the best hospital for pancreatic cancer in Germany: a hospital is chosen by three checkable things — whether it runs a certified pancreatic cancer centre, how many pancreatic operations its surgeons perform a year, and whether a tumour board, not one doctor, discusses each case. Families just handed the diagnosis almost always start with this question, as if one address could solve everything.
Below: how these centres work and differ, who works in the field, which documents are needed and what nobody can promise in advance. The treatment itself is covered on the page on pancreatic cancer treatment in Germany.
What Is the Best Hospital to Treat Pancreatic Cancer — And Why the Question Has No Single Answer
Families keep asking what is the best hospital to treat pancreatic cancer, and the honest reply is that German medicine works not with a league table but with certified centres, each audited against the same requirements. The useful question is whether a hospital meets them.
A centre certified by the German Cancer Society (DKG) as a Pankreaskarzinomzentrum (hospitals often write Pankreaskrebszentrum) commits to minimum yearly numbers of patients and operations, a fixed team of surgeon, gastroenterologist, medical oncologist, radiologist and pathologist, and a tumour board (Tumorkonferenz) for every case, checked by an annual audit; the page on cancer hospitals in Germany explains this system. A hospital without one may be strong in other fields yet wrong for this diagnosis, though a missing certificate alone does not mean a lack of experience.
Be wary of pages that promise a cure or publish a top-ten list: magazine rankings rely heavily on reputation surveys among doctors and say little about one particular tumour. Reliable information on the disease and on finding a certified centre is in the pancreatic cancer section of the Krebsinformationsdienst, the information service of the German Cancer Research Center.
What Actually Separates One Pancreatic Centre From Another
Operative volume comes first: pancreatic operations are among the most demanding in the abdomen, and the pancreatoduodenectomy (the Whipple operation: removal of the pancreatic head with the duodenum) goes measurably better where it is done often, as German data on major pancreatic resections show. Under the minimum-volume rules of the Federal Joint Committee (G-BA), complex pancreatic operations on adults are allowed only in hospitals that perform at least 20 a year, counted per site. Volume shifts the odds but does not guarantee anything.
Beyond volume, ask about four things:
- robotic or other minimally invasive access for suitable tumours;
- interventional endoscopy and endosonography in-house, for bile duct stents and tissue sampling;
- chemotherapy before surgery, not only after it;
- intensive care and pathology on the same site.
The tumour board takes the decision that shapes the whole plan: whether the tumour is resectable, borderline resectable or inoperable. That verdict decides whether treatment starts with surgery or chemotherapy; when surgery is impossible, especially with metastases, the approach changes, as explained on the page on stage 4 pancreatic cancer. Who sits on that board matters more than the hotel-like details of the ward.
Hospitals and Doctors Who Work in This Field
What follows are real examples of how such centres are built — not a ranking and not a recommendation.
- TUM Klinikum rechts der Isar, Munich: the Department of Surgery is headed by Prof. Helmut Friess, who previously held a professorship in pancreatic surgery; Prof. Roland Schmid directs Internal Medicine II there and works on pancreatic cancer research.
- München Klinik Bogenhausen: Prof. Ayman Agha is chief physician for visceral surgery and deputy head of the bowel and pancreatic cancer centres, with minimally invasive pancreatic surgery among his focuses; Dr Martin Fuchs, chief physician for gastroenterology, focuses on endoscopy and endosonography of the digestive organs, including diseases of the bile ducts and pancreas.
- Rotkreuzklinikum München: Prof. Wolfgang Thasler heads general, visceral, thoracic and minimally invasive surgery and leads the bowel and pancreatic cancer centres.
- Krankenhaus Nordwest, Frankfurt am Main: Prof. Thilo Welsch, chief physician for general, visceral and tumour surgery, focuses among other things on pancreatic and robotic oncological surgery.
- Vivantes Humboldt-Klinikum, Berlin: Prof. Ulrich Adam is chief physician for general and visceral surgery and heads the pancreatic cancer centre; his focuses include pancreatic, liver and robotic surgery.
- ISAR Klinikum, Munich: Prof. Franz Bader directs general, visceral and minimally invasive surgery, where the pancreas is a separate field and treatment is planned with gastroenterologists.
Drug treatment belongs to medical oncology — for example Prof. Stefan Böck, chief physician for haematology, oncology and palliative medicine at München Klinik Harlaching, whose focus is solid tumours and palliative medicine. He co-authored the German clinical guideline on pancreatic cancer. Still, the choice follows the case, not the list.
What to Prepare and What to Ask Before You Apply
Prepare the documents a German centre needs before it can say anything definite: CT or MRI of the abdomen on disc in DICOM format, not printouts; the histology report if a biopsy was done; CA 19-9 and liver values; discharge summaries; current medication; and a short note on weight loss, jaundice and pain.
Then ask the centre: is the tumour resectable, borderline or inoperable on these images; how many pancreatic resections does the team do a year; will a tumour board discuss the case, and when; is chemotherapy planned before surgery; who is the contact person?
The centre replies with an opinion and a cost estimate that covers only the planned steps and changes if the tumour board changes the plan. No honest centre promises a result by email, and waiting for a perfect answer costs time this diagnosis does not give. If the resectability decision leaves doubts, a second opinion from a German doctor can review it.
Frequently asked questions
Which country is the best for pancreatic cancer treatment?
No honest country ranking exists: the outcome depends on the tumour, the patient and the particular centre. The criteria are the same everywhere — surgical volume, a certified centre and a tumour board for every case. Germany makes them easy to check: G-BA rules fix the minimum volume, and certified centres are audited every year.
Where is pancreatic cancer treated best?
Where three checkable conditions meet: a pancreatic cancer centre certified by the German Cancer Society (Pankreaskarzinomzentrum), surgeons who perform these operations regularly, and a tumour board for every case. Current certificates can be found through OncoMap, the search tool for certified centres; ask the centre itself how many operations it did last year.
How many pancreatic operations should a hospital perform?
For complex pancreatic operations on adults, Germany sets a binding minimum of 20 a year per hospital site; a hospital that does not expect to reach it is, as a rule, not allowed to perform them. The minimum is a floor, not a mark of quality, so ask how many such operations the centre did last year.
How AlenMed Arranges Treatment
After a request, imaging, histology and discharge summaries are translated into German and sent to the doctors; the centre says whether it takes the case and what it proposes, and issues a cost estimate and the official invitation letter for the visa. In an acute situation the request goes to several centres at once, so the family does not wait on one reply.
AlenMed works with 345 doctors at 86 partner hospitals in 38 cities; the company office is in Munich. Pancreatic centres are spread across the country, so the search follows the case and the free slot, not the city. A coordinator meets the patient, interprets at consultations and when the tumour board’s decision is explained, and collects the discharge report.
This material is for information only and is not an offer; the treatment plan is set by a doctor at an in-person consultation.